Contralateral bulla neogenesis associated with postoperative recurrences of primary spontaneous pneumothorax in young patients.

Primary spontaneous pneumothorax (PSP) bulla neogenesis postoperative recurrence young

Journal

Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916

Informations de publication

Date de publication:
Dec 2019
Historique:
entrez: 8 2 2020
pubmed: 8 2 2020
medline: 8 2 2020
Statut: ppublish

Résumé

Video-assisted thoracoscopic surgery (VATS) is considered an acceptable treatment for recurrent primary spontaneous pneumothorax (PSP). However, recent reports have described a high postoperative recurrence rate in young patients with PSP. We hypothesized that ineffective VATS may have been performed for these patients (aged <25 years). We evaluated the factors preventing postoperative recurrence in young PSP patients in order to identify patients with effective surgery. Between April 2009 and December 2018, we retrospectively evaluated 92 patients aged <25 years who underwent first VATS bullectomy for PSP. Factors such as gender, smoking habit, history of contralateral PSP, family history, body mass index (BMI), and contralateral bulla neogenesis on high-resolution computed tomography were evaluated. The mean BMI was 18.8±1.8. Contralateral bulla neogenesis was present in 31 patients (33.7%). The median period of observation for postoperative recurrence was 401.5 days. Thirty cases (32.6%) developed postoperative recurrence. Univariate and multivariable analyses showed that a BMI ≥18.0 and no contralateral bulla neogenesis were significant factors preventing postoperative recurrence (P=0.018, hazard ratio: 0.41 and P=0.0046, hazard ratio: 0.25, respectively). Although the patients aged <25 years have a high rate of postoperative recurrence, the patients with BMI ≥18.0 and no contralateral bulla neogenesis have a significantly lower rate of postoperative recurrence rate.

Sections du résumé

BACKGROUND BACKGROUND
Video-assisted thoracoscopic surgery (VATS) is considered an acceptable treatment for recurrent primary spontaneous pneumothorax (PSP). However, recent reports have described a high postoperative recurrence rate in young patients with PSP. We hypothesized that ineffective VATS may have been performed for these patients (aged <25 years). We evaluated the factors preventing postoperative recurrence in young PSP patients in order to identify patients with effective surgery.
METHODS METHODS
Between April 2009 and December 2018, we retrospectively evaluated 92 patients aged <25 years who underwent first VATS bullectomy for PSP. Factors such as gender, smoking habit, history of contralateral PSP, family history, body mass index (BMI), and contralateral bulla neogenesis on high-resolution computed tomography were evaluated.
RESULTS RESULTS
The mean BMI was 18.8±1.8. Contralateral bulla neogenesis was present in 31 patients (33.7%). The median period of observation for postoperative recurrence was 401.5 days. Thirty cases (32.6%) developed postoperative recurrence. Univariate and multivariable analyses showed that a BMI ≥18.0 and no contralateral bulla neogenesis were significant factors preventing postoperative recurrence (P=0.018, hazard ratio: 0.41 and P=0.0046, hazard ratio: 0.25, respectively).
CONCLUSIONS CONCLUSIONS
Although the patients aged <25 years have a high rate of postoperative recurrence, the patients with BMI ≥18.0 and no contralateral bulla neogenesis have a significantly lower rate of postoperative recurrence rate.

Identifiants

pubmed: 32030229
doi: 10.21037/jtd.2019.12.05
pii: jtd-11-12-5124
pmc: PMC6988004
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5124-5129

Informations de copyright

2019 Journal of Thoracic Disease. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: The authors have no conflicts of interest to declare.

Références

J Cardiothorac Surg. 2019 Jan 23;14(1):20
pubmed: 30674336
Gen Thorac Cardiovasc Surg. 2019 May;67(5):464-469
pubmed: 30523543
Thorax. 2010 Aug;65 Suppl 2:ii18-31
pubmed: 20696690
Biosci Trends. 2015 Jun;9(3):193-7
pubmed: 26166373
Eur J Cardiothorac Surg. 2018 Apr 1;53(4):857-861
pubmed: 29155978
Surg Today. 2017 Jul;47(7):859-864
pubmed: 27909813
World J Surg. 2017 May;41(5):1274-1280
pubmed: 27909771
Ann Thorac Surg. 2018 Jul;106(1):184-191
pubmed: 29577928
Surg Today. 2017 Sep;47(9):1129-1134
pubmed: 28213720
Thorax. 1997 Sep;52(9):805-9
pubmed: 9371212
Chest. 2001 Feb;119(2):590-602
pubmed: 11171742
Asian J Surg. 2011 Apr;34(2):69-73
pubmed: 21723469
J Thorac Dis. 2016 Dec;8(12):3676-3681
pubmed: 28149563
Lancet. 2013 Apr 13;381(9874):1277-82
pubmed: 23489754
Eur Respir J. 2015 Aug;46(2):321-35
pubmed: 26113675
Surg Today. 2016 Jun;46(6):668-85
pubmed: 26289837
Interact Cardiovasc Thorac Surg. 2015 Aug;21(2):195-9
pubmed: 25924869

Auteurs

Kenji Tsuboshima (K)

Department of Thoracic Surgery and Pneumothorax Center, Takasago Municipal Hospital, Takasago, Japan.

Yasumi Matoba (Y)

Department of Thoracic Surgery and Pneumothorax Center, Takasago Municipal Hospital, Takasago, Japan.

Teppei Wakahara (T)

Department of Thoracic Surgery and Pneumothorax Center, Takasago Municipal Hospital, Takasago, Japan.

Classifications MeSH